Absence of a Relationship Between Vitamin D and Graves' Orbitopathy

Overview

Journal J Endocrinol Invest

Publisher Springer

Specialty Endocrinology

Date 2023 Jan 25

PMID 36696067

Authors

G Lanzolla

L Di Matteo

S Comi

G Cosentino

F Menconi

M N Maglionico

C Posarelli

M Figus

M Marino

Affiliations

Soon will be listed here.

Citing Articles

The Role of Vitamin D3 in Ocular Diseases.

Mrugacz M, Pienczykowska K, Bryl A Nutrients. 2024; 16(12).

PMID: 38931233 PMC: 11206323. DOI: 10.3390/nu16121878.

References

Gallo D, Mortara L, Gariboldi M, Cattaneo S, Rosetti S, Gentile L . Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review. J Endocrinol Invest. 2019; 43(4):413-429. DOI: 10.1007/s40618-019-01123-5. View

Charoenngam N, Holick M . Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients. 2020; 12(7). PMC: 7400911. DOI: 10.3390/nu12072097. View

Hahn J, Cook N, Alexander E, Friedman S, Walter J, Bubes V . Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022; 376:e066452. PMC: 8791065. DOI: 10.1136/bmj-2021-066452. View

Khamisi S, Lundqvist M, Rasmusson A, Engstrom B, Karlsson F, Ljunggren O . Vitamin D and bone metabolism in Graves' disease: a prospective study. J Endocrinol Invest. 2022; 46(2):425-433. PMC: 9859854. DOI: 10.1007/s40618-022-01927-y. View

Bartalena L, Kahaly G, Baldeschi L, Dayan C, Eckstein A, Marcocci C . The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy. Eur J Endocrinol. 2021; 185(4):G43-G67. DOI: 10.1530/EJE-21-0479. View

Lanzolla G, Puccinelli L, Giudetti M, Comi S, Menconi F, Maglionico M . Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy. J Endocrinol Invest. 2022; 46(2):337-344. PMC: 9859920. DOI: 10.1007/s40618-022-01906-3. View

Bartalena L, Piantanida E, Gallo D, Lai A, Tanda M . Epidemiology, Natural History, Risk Factors, and Prevention of Graves' Orbitopathy. Front Endocrinol (Lausanne). 2020; 11:615993. PMC: 7734282. DOI: 10.3389/fendo.2020.615993. View

Nicoli F, Lanzolla G, Mantuano M, Ionni I, Mazzi B, Leo M . Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy. J Endocrinol Invest. 2020; 44(3):581-585. DOI: 10.1007/s40618-020-01353-y. View

Lanzolla G, Menconi F, Nicoli F, Posarelli C, Maglionico M, Figus M . Beneficial effect of low-dose radioiodine ablation for Graves' orbitopathy: results of a retrospective study. J Endocrinol Invest. 2021; 44(12):2575-2579. PMC: 8572201. DOI: 10.1007/s40618-021-01544-1. View

10.

Planck T, Shahida B, Malm J, Manjer J . Vitamin D in Graves Disease: Levels, Correlation with Laboratory and Clinical Parameters, and Genetics. Eur Thyroid J. 2018; 7(1):27-33. PMC: 5836255. DOI: 10.1159/000484521. View

11.

Gallo D, Mortara L, Veronesi G, Cattaneo S, Genoni A, Gallazzi M . Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves' Disease Hyperthyroidism During Methimazole Treatment. Front Endocrinol (Lausanne). 2022; 13:886451. PMC: 9240752. DOI: 10.3389/fendo.2022.886451. View

12.

Appunni S, Rubens M, Ramamoorthy V, Saxena A, Tonse R, Veledar E . Association between vitamin D deficiency and hypothyroidism: results from the National Health and Nutrition Examination Survey (NHANES) 2007-2012. BMC Endocr Disord. 2021; 21(1):224. PMC: 8590325. DOI: 10.1186/s12902-021-00897-1. View